HU-331

CCCCCC1=CC(=O)C([C@@H]2C=C(C)CC[C@H]2C(C)=C)=C(O)C1=O

InChIKey=WDXXEUARVHTWQF-DLBZAZTESA-N

InChI=1S/C21H28O3/c1-5-6-7-8-15-12-18(22)19(21(24)20(15)23)17-11-14(4)9-10-16(17)13(2)3/h11-12,16-17,24H,2,5-10H2,1,3-4H3/t16-,17+/m0/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

PubMed

Title	Date	PubMed
Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator.	1998 Oct	9778318
A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells.	2006 Jul	16571653
HU-331 is a catalytic inhibitor of topoisomerase IIα.	2014 Dec 15	25409338
Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol.	2014 May 25	24667653

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:26:41 GMT 2023` Edited by `admin` on `Sat Dec 16 09:26:41 GMT 2023`
Record UNII	I7Q196L4AU
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

HU-331

Common Name

English

2,5-CYCLOHEXADIENE-1,4-DIONE, 3-HYDROXY-2-(3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-, (1R-TRANS)-

Systematic Name

English

2,5-CYCLOHEXADIENE-1,4-DIONE, 3-HYDROXY-2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-

Systematic Name

English

Code System Code Type Description

PUBCHEM

11393311